Immune Thrombocytopenia (ITP) Immune-Genetic Assessment

• Conditions: Thrombocytopenia

• Registration Number: NCT01196884
• Lead Sponsor: Azienda Sanitaria-Universitaria Integrata di Udine

Brief Summary

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-09
• Study Start: 2010-09
• Study First Submitted: 2010-09-07
• Study First Submitted QC: 2010-09-08
• Study First Posted: 2010-09-09
• Last Update Submitted: 2018-03-19
• Last Update Posted: 2018-03-20

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

• Adult patients with primary ITP

Exclusion Criteria

• Secondary ITP

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (13)

Istituto di Ematologia L. & A. Seragnoli; 🇮🇹 Bologna, Italy

Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco; 🇮🇹 Cagliari, Italy

UF Ematologia, Policlinico di Careggi; 🇮🇹 Firenze, Italy

U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico; 🇮🇹 Milano, Italy

Department of Oncology/Haematology, Niguarda Ca'Granda Hospital; 🇮🇹 Milano, Italy

Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro; 🇮🇹 Novara, Italy

Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro"; 🇮🇹 Novara, Italy

Department of Medical and Surgical Sciences, University of Padova; 🇮🇹 Padova, Italy

Oncology-Hematology Department, "S. Maria delle Croci" Hospital; 🇮🇹 Ravenna, Italy

Institute of Hematology, Catholic University,; 🇮🇹 Roma, Italy

Scroll for more (3 remaining)